Table 2 Standardized incidence ratios for each cancer according to type of rheumatic disease a
From: Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study
Site of cancer | RA | SLE | SSc | DM | PM | |
|---|---|---|---|---|---|---|
Breast | O/E | 10/12.509 | 4/5.883 | 0/1.653 | 0/0.492 | 0/0.282 |
SIR (CI) | 0.799 (0.304 to 1.295) | 0.68 (0.185 to 1.741) | 0 (0 to 2.231) | 0 (0 to 7.492) | 0 (0 to 13.088) | |
Cervical | O/E | 4/3.786 | 7/1.635 | 0/0.47 | 0/0.136 | 0/0.085 |
SIR (CI) | 1.056 (0.288 to 2.705) | 4.282 (1.722 to 8.824) | 0 (0 to 7.846) | 0 (0 to 27.198) | 0 (0 to 43.353) | |
Colorectal | O/E | 13/18.514 | 5/3.933 | 1/1.803 | 0/0.491 | 0/0.386 |
SIR (CI) | 0.702 (0.32 to 1.084) | 1.271 (0.413 to 2.967) | 0.555 (0.014 to 3.09) | 0 (0 to 7.518) | 0 (0 to 9.55) | |
Endometrial | O/E | 0/1.883 | 0/0.742 | 0/0.238 | 2/0.066 | 0/0.044 |
SIR (CI) | 0 (0 to 1.959) | 0 (0 to 4.974) | 0 (0 to 15.512) | 30.529 (3.697 to 110.283) | 0 (0 to 84.476) | |
Lung | O/E | 14/15.667 | 0/2.637 | 7/1.424 | 2/0.363 | 0/0.319 |
SIR (CI) | 0.894 (0.489 to 1.499) | 0 (0 to 1.399) | 4.917 (1.977 to 10.131) | 5.514 (0.668 to 19.917) | 0 (0 to 11.546) | |
NHL | O/E | 8/2.462 | 5/0.675 | 1/0.242 | 1/0.071 | 0/0.049 |
SIR (CI) | 3.387 (1.462 to 6.673) | 7.408 (2.405 to 17.287) | 4.141 (0.105 to 23.071) | 14.088 (0.357 to 78.491) | 0 (0 to 74.764) | |
Stomach | O/E | 15/22.625 | 3/5.027 | 2/2.236 | 1/0.614 | 1/0.473 |
SIR (CI) | 0.663 (0.327 to 0.998) | 0.597 (0.123 to 1.744) | 0.898 (0.109 to 3.245) | 1.629 (0.041 to 9.076) | 2.113 (0.054 to 11.774) | |
Thyroid | O/E | 14/14.957 | 11/7.111 | 0/1.829 | 1/0.633 | 0/0.318 |
SIR (CI) | 0.936 (0.446 to 1.426) | 1.547 (0.633 to 2.461) | 0 (0 to 2.017) | 1.58 (0.04 to 8.805) | 0 (0 to 11.601) | |